M&T Bank
OREX

M&T Bank’s Orexigen Therapeutics, Inc. OREX Stock Holding History

M&T Bank’s Portfolio OREX Stock Details OREX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-2,605
Closed -$129K – 2216
2015
Q2 		$129K Sell
2,605
-256
-9% -$15.3K ﹤0.01% 1851
2015
Q1 		$223K Buy
2,861
+845
+42% +$52.4K ﹤0.01% 1677
2014
Q4 		$122K Sell
2,016
-1,834
-48% -$92.1K ﹤0.01% 1850
2014
Q3 		$164K Buy
+3,850
New +$207K ﹤0.01% 1941

Other funds holding OREX

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
SC
Samlyn Capital New York $5.86B AUM 36.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
FCMI
Foresite Capital Management II Larkspur, California $29.2M AUM 44.84% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

M&T Bank's OREX Position: Q3 2015 in Review

M&T Bank sold out of Orexigen Therapeutics, Inc. (OREX) in Q3 2015, closing a stake of 2,605 shares — an estimated $129K sold.

M&T Bank first reported a position in OREX in Q3 2014 and held it in 4 quarters. The position peaked at $223K in Q1 2015. 132 funds tracked by Wall St. Rank hold OREX as of Q3 2015.

  • M&T Bank reported no remaining Orexigen Therapeutics, Inc. position as of Q3 2015 after selling out during the quarter.
  • M&T Bank sold 2,605 Orexigen Therapeutics, Inc. shares in Q3 2015, an estimated $129K.
  • M&T Bank first reported a position in Orexigen Therapeutics, Inc. in Q3 2014 and held it in 4 quarters.
  • M&T Bank's Orexigen Therapeutics, Inc. position peaked at $223K in Q1 2015.
  • 132 funds tracked by Wall St. Rank held Orexigen Therapeutics, Inc. as of Q3 2015.

Based on M&T Bank's 13F filing for Q3 2015, filed 13 Nov 2015.